What are Antifibrotic drugs?

Antifibrotic drugs are pharmacologic agents that share a common mechanism (typically targeting TGF-β). 0 are currently marketed, with 3 more in clinical development.

Antifibrotic

0 marketed 2 in Phase 3 1 in Phase 2

This page covers all Antifibrotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TGF-β, TGF-β receptor.

Targets

TGF-β · TGF-β receptor

Phase 3 pipeline (2)

Topical Pirfenidone · Centro Dermatológico Dr. Ladislao de la Pascua · Pulmonology
Pirfenidone is an antifibrotic agent that inhibits the production of transforming growth factor-beta (TGF-β), a key cytokine involved in fibrosis.
Pirfenidone Oral Product · Capital Medical University · Pulmonology
Pirfenidone is an antifibrotic agent that inhibits the production of transforming growth factor-beta (TGF-β), a key cytokine involved in fibrosis.

Phase 2 pipeline (1)

Pirfenidone Capsules（600mg） · Beijing Continent Pharmaceutical Co, Ltd. · Respiratory
Antifibrotic agent